Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy

Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy

<b>Background and Aims:</b> Due to increasing knowledge of the “gut–liver axis”, there has been growing interest regarding the use of fecal microbiota transplant in the management of chronic liver disease. There are limited data available and current guidelines are mostly based on expert...

Full description

Bibliographic Details
Main Authors:	Annie S. Hong, Kyaw Min Tun, Jenny M. Hong, Kavita Batra, Gordon Ohning
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Antibiotics
Subjects:	fecal microbiota transplant decompensated cirrhosis <i>Clostridioides difficile</i> infection hepatic encephalopathy
Online Access:	https://www.mdpi.com/2079-6382/11/7/838

Similar Items

Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of <i>Clostridioides difficile</i> Infection among Pediatric Patients: A Systematic Review and Meta-Analysis
by: Kyaw Min Tun, et al.
Published: (2022-12-01)

Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)

Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)

Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study
by: Wasit Wongtrakul, et al.
Published: (2025-02-01)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
by: Hyuk Yoon, et al.
Published: (2021-01-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
by: Yan Lan, et al.
Published: (2024-11-01)

The Efficacy of Fecal Microbiota Transplantation in Mouse Models Infected with <i>Clostridioides difficile</i> from the Perspective of Metabolic Profiling: A Systematic Review
by: Anna Voziki, et al.
Published: (2024-12-01)

Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study
by: Shanghao Liu, et al.
Published: (2024-11-01)

Impact of COVID-19 on Patients with Decompensated Liver Cirrhosis
by: Tudor Voicu Moga, et al.
Published: (2023-02-01)

In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent <i>Clostridioides difficile</i> Infection
by: Monica Dahiya, et al.
Published: (2023-04-01)

Thyroid hormone profile is related to prognosis in acute decompensation of cirrhosis
by: Giovana De Nardin, et al.
Published: (2024-09-01)

Palmitoylcarnitine impairs immunity in decompensated cirrhosis
by: Ingrid Wei Zhang, et al.
Published: (2024-11-01)

Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study
by: Yinglun Li, et al.
Published: (2024-12-01)

Efficacy of albumin use in decompensated cirrhosis and real‐world adoption in Australia
by: Eric Kalo, et al.
Published: (2024-09-01)

Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study
by: Simon Johannes Gairing, et al.
Published: (2024-08-01)

A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory <i>Clostridioides difficile</i> Infection
by: Tanya M. Monaghan, et al.
Published: (2021-11-01)

Effect and safety analysis of Yiqi Yangxue Jiedu decoction combined with entecavir in the treatment of male patients with decompensated hepatitis B cirrhosis
by: Mingli Jia
Published: (2025-02-01)

Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center
by: R. Quera, et al.
Published: (2024-10-01)

Construction and evaluation of a nomogram prediction model for bacterial infection in patients with decompensated hepatitis C cirrhosis
by: XUE Linlin, et al.
Published: (2023-01-01)

Encapsulation protocol for fecal microbiota transplantation
by: Dávid Sipos, et al.
Published: (2024-06-01)

Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic <i>Clostridioides difficile</i> Colonization and Infection
by: Sung-Hee Han, et al.
Published: (2020-06-01)

Spleen stiffness measurements during recompensation in patients with acutely decompensated liver cirrhosis: preliminary findings of a pilot study
by: Dilan Elcin Gülcicegi, et al.
Published: (2024-11-01)

Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
by: Elisa Martinez, et al.
Published: (2022-07-01)

Predictive Factors and Nomogram for Spontaneous Bacterial Peritonitis in Decompensated Cirrhosis Among the Elderly
by: Yan F, et al.
Published: (2024-12-01)

Effectiveness of albumin infusion for the management of hyponatremia in decompensated cirrhosis: a systematic review
by: Akash Roy, et al.
Published: (2024-06-01)

Construction and Application of Patient-Participated Health Care Guidance Plan for Patients with Decompensated Hepatitis B Cirrhosis
by: Su D, et al.
Published: (2024-06-01)

The Relationship of Plasma Zinc Concentration and Hepatic Encephalopathy in Patients with Cirrhosis
by: Rahmatollah Rafiei, et al.
Published: (2014-11-01)

Value of Acute Kidney Injury in Predicting Mortality in Vietnamese Patients with Decompensated Cirrhosis
by: Nghia N. Nguyen, et al.
Published: (2022-03-01)

Minimal hepatic encephalopathy - from cirrhosis to neurological disorders
by: Jakub Jarmołowicz, et al.
Published: (2024-12-01)

Fecal Microbiota Transplantation in Liver Cirrhosis
by: Adrian Boicean, et al.
Published: (2023-10-01)

Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis
by: Ning Gao, et al.
Published: (2024-06-01)

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection from a Randomized Controlled Trial and Review of the Literature
by: R. E. Ooijevaar, et al.
Published: (2021-03-01)

Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent <i>Clostridioides difficile</i> Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study
by: Jing-Han Chen, et al.
Published: (2024-06-01)

D-dimer-to-platelet count ratio as a novel indicator for predicting prognosis in HBV-related decompensated cirrhosis
by: Xia He, et al.
Published: (2024-03-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01)

Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU
by: Nicolas Weiss, et al.
Published: (2024-04-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)